IA14 Induction in Young Acute Myeloid Leukemia

NCT04069208 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Idarubicin and cytarabine induction

Sponsor

Peking Union Medical College Hospital